½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1507766

¼¼°èÀÇ Á¤¹Ð Áø´Ü ½ÃÀå : ±Ô¸ðº°, À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Precision Diagnostics Market Size study, by Type (Genetic Tests, Esoteric Tests, Others) by Application (Oncology, Cardiovascular, Neurology, Others) by End User (Hospitals, Clinical Laboratories, Homecare) and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Á¤¹Ð Áø´Ü ½ÃÀåÀº 2023³â¿¡ ¾à 758¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2032³â¿¡ °ÉÃÄ 13.10% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Á¤¹Ð Áø´ÜÇÐÀº ȯÀÚÀÇ Áúº´ÀÇ Æ¯Á¤ ¿øÀΰú ¼ºÁúÀ» Á¤È®ÇÏ°Ô È®ÀÎÇϱâ À§ÇØ °í±Þ ±â¼úÀ» ÀÌ¿ëÇÏ´Â ÀÇ·á Áø´ÜÇÐ ºÐ¾ß¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº Áø´Ü ±â¼úÀ» °³º° ȯÀÚÀÇ Æ¯¼º¿¡ ¸Â°Ô Á¶Á¤ÇÏ´Â °ÍÀ¸·Î, Á¾Á¾ ´õ Á¤È®ÇÑ Áø´ÜÀ» ´Þ¼ºÇϱâ À§ÇØ À¯ÀüÀÚ, ºÐÀÚ ¹× ¼¼Æ÷ ºÐ¼®À» ÅëÇÕÇÕ´Ï´Ù. ¸ñÇ¥´Â º¸´Ù °³ÀÎÈ­µÇ°í È¿°úÀûÀÎ Ä¡·á °èȹÀ» °¡´ÉÇÏ°Ô ÇÏ°í ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ´Â °ÍÀÔ´Ï´Ù. ÀΰøÁö´É(AI)ÀÇ ÅëÇÕÀÌ ÁøÇàµÇ°í ÀÖ´Â °ÍÀÌ, ¼¼°è Á¤¹Ð Áø´Ü ½ÃÀåÀÇ È®´ë¸¦ µÞ¹ÞħÇÏ°í ÀÖ½À´Ï´Ù. AI´Â °í±Þ µ¥ÀÌÅÍ ºÐ¼®, ¿¹Ãø ¸ðµ¨¸µ ¹× ¸ÂÃã Ä¡·á °èȹÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á Áø´ÜÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ³ôÀÔ´Ï´Ù. ÀÌ Çõ½ÅÀº Áúº´ÀÇ Á¶±â ¹ß°ßÀ» °¡¼ÓÈ­ÇÏ°í ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í ¼¼°è °Ç°­ °ü¸® °üÇàÀ» º¯È­½Ãŵ´Ï´Ù.

¾Ï, ½ÉÇ÷°ü Áúȯ, ´ç´¢º´ µî ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡´Â Á¤¹Ð Áø´Ü ¼ö¿ä¸¦ ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. Á¶±â ¹ß°ß°ú °³ÀÎÈ­µÈ Ä¡·á °èȹÀº ÀÌ·¯ÇÑ Áúº´À» È¿°úÀûÀ¸·Î °ü¸®ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ Á¤¹Ð Áø´ÜÀº °³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸Â°Ô Ä¡·á °èȹÀ» Á¶Á¤ÇÏ´Â ¸ÂÃãÇü ÀÇ·á¿¡¼­µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº Ä¡·á È¿°ú¸¦ ³ôÀÌ°í ºÎÀÛ¿ëÀ» ÁÙÀ̱â À§ÇØ Á¤¹Ð Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀÔ´Ï´Ù. ¶ÇÇÑ Á¤¹Ð Áø´ÜÀÇ ÀÌÁ¡¿¡ ´ëÇÑ °Ç°­ °ü¸® Àü¹®°¡¿Í ȯÀÚÀÇ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀ̵Ǿú½À´Ï´Ù. ¿©±â¿¡´Â ´õ ³ªÀº Áúº´ °ü¸®, ȯÀÚÀÇ ¿¹ÈÄ °³¼±, Àå±âÀûÀÎ ºñ¿ë Àý°¨ µîÀÌ Æ÷ÇԵ˴ϴÙ. ±×·¯³ª ±ÔÁ¦ ¿ä°ÇÀÌ ¾ö°ÝÇÏ°í Ç¥ÁØÈ­°¡ ÁøÇàµÇÁö ¾ÊÀº °ÍÀÌ ¿¹Ãø±â°£ÀÎ 2024-2032³â ¼¼°è Á¤¹Ð Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤¹Ð Áø´Ü ½ÃÀå Á¶»ç¿¡¼­ °í·ÁÇÑ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÔ´Ï´Ù. 2023³â¿¡´Â ºÏ¹Ì°¡ ¼öÀ͸鿡¼­ Áö¹èÀûÀÎ Áö¿ªÀ̾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÁ¡Àº Á¤ºÎ¿Í ¹Î°£ Á¶Á÷ °£ÀÇ ÆÄÆ®³Ê½Ê Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ °ß°íÇÑ °Ç°­ °ü¸® ÀÎÇÁ¶ó°¡ Áö¿ª ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù. ÀÌ Áö¿ªÀÇ Áß¿äÇÑ ±â¾÷ÀÎ Neuberg Diagnostics Private Limited´Â ¸ÂÃãÇü ÀÇ·á¿¡¼­ÀÇ Âü½ÅÇÑ ±â¼ú°ú ¼Ö·ç¼ÇÀ» È°¿ëÇϱâ À§ÇØ ±¹³» ¹× À¯·´¿¡ »õ·Î¿î ÀÎÅ¥º£ÀÌ¼Ç ¼¾Å͸¦ ¼³¸³ÇÏ¿© ±¹³»¿Ü ÁøÃâÀ» È®´ë °èȹÀÔ´Ï´Ù. 2021³â 7¿ù, ȸ»ç´Â ÀεµÀÇ Å׶û°¡³ª ÁÖ¿¡ »õ·Î¿î º´¸® ¿¬±¸¼Ò¸¦ °³¼³Çß½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ´Ù¸¥ ½ÃÀå ÁøÃâ ±â¾÷¿¡ ÀÇÇÑ À¯»çÇÑ ³ë·ÂÀº ÀÌ Áö¿ªÀÇ Àü¸ÁÀ» Å©°Ô °­È­ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø±â°£ÀÎ 2024³âºÎÅÍ 2032³â±îÁö °¡Àå ±Þ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°è Á¤¹Ð Áø´Ü ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ »çÇ×
    • °ø±ÞÃø ºÐ¼®
      • °¡¿ë¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ ½ÃÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼úÀÇ Áøº¸
      • ȯ°æ¿¡ÀÇ ¹è·Á
      • ¼ÒºñÀÚÀÇ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó³âµµ
  • ȯÀ² º¯È¯À²

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • Á¤¹Ð Áø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022³â-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±â ÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦3Àå Á¤¹Ð Áø´Ü ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÇ °úÁ¦
  • ½ÃÀå ±âȸ

Á¦4Àå Á¤¹Ð Áø´Ü ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
    • Porter's Five Forces¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • Æı«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå Á¤¹Ð Áø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Çüº°(2022³â-2032³â)

  • À¯ÀüÀÚ °Ë»ç
  • ¿¡¼ÒÅ׸¯ °Ë»ç
  • ±âŸ

Á¦6Àå Á¤¹Ð Áø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°(2022³â-2032³â)

  • ¾Ï ¿µ¿ª
  • ¼øȯ±â
  • ½Å°æ°è
  • ±âŸ

Á¦7Àå Á¤¹Ð Áø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°(2022³â-2032³â)

  • º´¿ø
  • ÀÓ»ó ½ÇÇè½Ç
  • ÀçÅÃÄ¡·á

Á¦8Àå Á¤¹Ð Áø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°(2022³â-2032³â)

  • ºÏ¹ÌÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • ¹Ì±¹
      • À¯Çüº°, ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø(2022³â-2032³â)
      • ¿ëµµº°, ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø(2022³â-2032³â)
      • ÃÖÁ¾ »ç¿ëÀÚº°, ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø(2022³â-2032³â)
    • ij³ª´Ù Á¤¹Ð Áø´Ü ½ÃÀå
  • À¯·´ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • ¿µ±¹ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • µ¶ÀÏÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • ÇÁ¶û½º Á¤¹Ð Áø´Ü ½ÃÀå
    • ½ºÆäÀÎ Á¤¹Ð Áø´Ü ½ÃÀå
    • ÀÌÅ»¸®¾ÆÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • ±âŸ À¯·´ Á¤¹Ð Áø´Ü ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç Á¤¹Ð Áø´Ü ½ÃÀå
    • Áß±¹ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • ÀεµÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • ÀϺ»ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • È£ÁÖ Á¤¹Ð Áø´Ü ½ÃÀå
    • Çѱ¹ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
  • ¶óƾ¾Æ¸Þ¸®Ä« Á¤¹Ð Áø´Ü ½ÃÀå
    • ºê¶óÁú Á¤¹Ð Áø´Ü ½ÃÀå
    • ¸ß½ÃÄÚ Á¤¹Ð Áø´Ü ½ÃÀå
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • »ç¿ìµð¾Æ¶óºñ¾Æ Á¤¹Ð Áø´Ü ½ÃÀå
    • ³²¾ÆÇÁ¸®Ä«ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¤¹Ð Áø´Ü ½ÃÀå

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Abbott Laboratories
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ ÀÌ¿ë°¡´É¼º¿¡ µû¸§)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • bioMerieux SA
    • Becton, Dickinson and Company
    • Danaher Corporation
    • QIAGEN NV
    • Hologic Inc.
    • Agilent Technologies Inc.

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
BJH 24.07.12

Global Precision Diagnostics Market is valued approximately USD 75.85 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 13.10% over the forecast period 2024-2032. Precision diagnostics refers to a field of medical diagnostics that utilizes advanced technologies to precisely identify the specific cause or nature of a patient's disease. This approach tailors diagnostic techniques to the individual characteristics of each patient, often incorporating genetic, molecular, and cellular analysis to achieve a more accurate diagnosis. The goal is to enable more personalized and effective treatment plans, improving patient outcomes. The growing integration of Artificial Intelligence (AI) is driving the expansion of the global precision diagnostics market. AI enhances diagnostic accuracy and efficiency by enabling advanced data analysis, predictive modeling, and personalized treatment plans. This innovation accelerates early disease detection and improves patient outcomes, fueling market growth and transforming healthcare practices worldwide.

The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, and diabetes drives the demand for precision diagnostics. Early detection and personalized treatment plans are crucial in managing these conditions effectively. Also, precision diagnostics play a critical role in personalized medicine, which tailors treatment plans to individual genetic profiles. This approach enhances treatment efficacy and reduces adverse effects, thereby increasing the demand for precision diagnostics. Additionally, increased awareness among healthcare professionals and patients about the benefits of precision diagnostics is driving market growth. This includes better disease management, improved patient outcomes, and cost savings in the long run. However, the stringent regulatory requirements, and lack of standardization are expected to hinder the Global Precision Diagnostics Market growth during the forecast period 2024-2032.

The key regions considered for the Global Precision Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the dominating region in terms of revenue. This dominance is due to the increasing partnerships between government and private organizations. Additionally, a robust healthcare infrastructure will facilitate regional growth. Neuberg Diagnostics Private Limited, a significant player in this region, plans to broaden its domestic and international reach by creating new incubation centers across the country and in Europe to leverage novel technologies and solutions in personalized medicine. In July 2021, the company also opened a new pathology lab in Telangana, India. Comparable initiatives by other market players in the region will significantly enhance the regional outlook in the. Whereas, the Asia Pacific is expected to be the fastest growing region during the forecast period 2024-2032.

Major market player included in this report are:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • bioMerieux SA
  • Becton, Dickinson and Company
  • Danaher Corporation
  • QIAGEN N.V.
  • Hologic Inc.
  • Agilent Technologies Inc.

The detailed segments and sub-segment of the market are explained below:

By Type

  • Genetic Tests
  • Esoteric Tests
  • Others

By Application

  • Oncology
  • Cardiovascular
  • Neurology
  • Others

By End User

  • Hospitals
  • Clinical Laboratories
  • Homecare

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Precision Diagnostics Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Precision Diagnostics Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Type
    • 2.3.2. By Application
    • 2.3.3. By End User
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Precision Diagnostics Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Precision Diagnostics Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Precision Diagnostics Market Size & Forecasts by Type 2022-2032

  • 5.1. Genetic Tests
  • 5.2. Esoteric Tests
  • 5.3. Others

Chapter 6. Global Precision Diagnostics Market Size & Forecasts by Application 2022-2032

  • 6.1. Oncology
  • 6.2. Cardiovascular
  • 6.3. Neurology
  • 6.4. Others

Chapter 7. Global Precision Diagnostics Market Size & Forecasts by End User 2022-2032

  • 7.1. Hospitals
  • 7.2. Clinical Laboratories
  • 7.3. Homecare

Chapter 8. Global Precision Diagnostics Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Precision Diagnostics Market
    • 8.1.1. U.S. Precision Diagnostics Market
      • 8.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.1.1.3. End User breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Precision Diagnostics Market
  • 8.2. Europe Precision Diagnostics Market
    • 8.2.1. U.K. Precision Diagnostics Market
    • 8.2.2. Germany Precision Diagnostics Market
    • 8.2.3. France Precision Diagnostics Market
    • 8.2.4. Spain Precision Diagnostics Market
    • 8.2.5. Italy Precision Diagnostics Market
    • 8.2.6. Rest of Europe Precision Diagnostics Market
  • 8.3. Asia-Pacific Precision Diagnostics Market
    • 8.3.1. China Precision Diagnostics Market
    • 8.3.2. India Precision Diagnostics Market
    • 8.3.3. Japan Precision Diagnostics Market
    • 8.3.4. Australia Precision Diagnostics Market
    • 8.3.5. South Korea Precision Diagnostics Market
    • 8.3.6. Rest of Asia Pacific Precision Diagnostics Market
  • 8.4. Latin America Precision Diagnostics Market
    • 8.4.1. Brazil Precision Diagnostics Market
    • 8.4.2. Mexico Precision Diagnostics Market
    • 8.4.3. Rest of Latin America Precision Diagnostics Market
  • 8.5. Middle East & Africa Precision Diagnostics Market
    • 8.5.1. Saudi Arabia Precision Diagnostics Market
    • 8.5.2. South Africa Precision Diagnostics Market
    • 8.5.3. Rest of Middle East & Africa Precision Diagnostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Abbott Laboratories
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. F. Hoffmann-La Roche Ltd.
    • 9.3.3. Siemens Healthineers AG
    • 9.3.4. Thermo Fisher Scientific Inc.
    • 9.3.5. bioMerieux SA
    • 9.3.6. Becton, Dickinson and Company
    • 9.3.7. Danaher Corporation
    • 9.3.8. QIAGEN N.V.
    • 9.3.9. Hologic Inc.
    • 9.3.10. Agilent Technologies Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦